THERANOSTICS PLATFORM AND METHODS OF USE

摘要

Theranostics platforms for identifying drugs and nutraceuticals for treatment of rare disease are described. The platforms comprise (a) a cell-phenotype image-enhancing instrument; (b) a drug/nutraceutical library; and (c) a computer-implemented system for analyzing a response of an optically- visible rare-disease cell phenotype to a drug or nutraceutical from the drug/nutraceutical library.